Rallybio FY 2021: net loss $47.0M; diluted EPS −$1.84

Key figures from this report

These are the numbers Rallybio reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Net income−$47.0MNo year-earlier figure tagged10-K income statement, on EDGAR
2. Diluted EPS−$1.84No year-earlier figure tagged10-K income statement, on EDGAR
3. Cash and cash equivalents$175.3MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
4. Cash from operations−$45.5MNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables